HD-OPM Archive
Hashtags

#medicalresearch

8 posts

Statins neither cause nor cure cancer: meta-analyses of randomized trials show no effect

Dec 31, 2024 · Gokhan Can ♥ 9 · 💬 4 Statins

Reviews the evidence on statins and cancer. A 2012 meta-analysis of 134,537 participants in 22 RCTs found identical cancer incidence (1.4% per year) and mortality (0.5% per year) in statin users and non-users, and a 2023 meta-analysis of 35 RCTs found the same. Anticancer effects in specific contexts remain preclinical or suggestive.

Lepodisiran siRNA cut Lp(a) by 93.9% at 400 mg in a 320-person NEJM trial

May 07, 2025 · Louis Nervegna ♥ 15 · 💬 1 Lp(a)

Luigi Fontana's summary of an NEJM trial of lepodisiran, an siRNA that blocks hepatic Lp(a) production. At the 400 mg dose Lp(a) fell by 93.9% placebo-adjusted, lasting up to a year, with only mild injection-site reactions. It offers a potential option for people with genetically high Lp(a) who cannot lower it with lifestyle or standard drugs.

Anabolic steroid users had 3x heart attack and 8.9x cardiomyopathy risk (Circulation)

Mar 15, 2025 · Louis Nervegna ♥ 4 · 💬 5 Hormones, women's & men's health

Louis notes that excess exogenous testosterone is also an anabolic steroid and shares Luigi Fontana's summary of a Circulation study comparing 1,189 anabolic androgenic steroid users with 59,450 controls over 11 years. Users had several-fold higher risks of heart attack, revascularization, clots, arrhythmias, cardiomyopathy and heart failure.

Statin use linked to 35% lower odds of liver cancer in UK database study

Sep 15, 2026 · Louis Nervegna ♥ 10 Statins

A UK Clinical Practice Research Datalink case-control study of 3,719 liver cancer cases and 14,876 controls found statin users had 35% lower odds of liver cancer, and cholesterol absorption inhibitors (ezetimibe class) 31% lower odds. This is an association, not proof, and non-statin findings need replication.

Amyloid-beta drives excess astrocyte cholesterol and impairs brain waste clearance in mice

Nov 03, 2026 · Louis Nervegna ♥ 2 Brain health & dementia

A Nature Neuroscience mouse study found amyloid-beta raises calcium activity in astrocytes, boosting cholesterol production and removing AQP4 water channels, which impairs the glymphatic waste-clearing system. Calming astrocytes, blocking cholesterol synthesis or giving atorvastatin restored clearance and memory in mice. Human trials are needed, but the mechanism may partly explain observational links between statin use and lower dementia risk.